Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer implements new branding strategy
Pharma Times, UK
Monday, November 8, 2010 - 9:36am
tags:
Bayer, branding
Allos Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript
Seeking Alpha
Monday, November 8, 2010 - 9:34am
tags:
earnings, Allos
What Is Avanir Pharmaceuticals Really Worth?
Seeking Alpha
Monday, November 8, 2010 - 9:33am
tags:
Avanir
Pfizer Arthritis Pill, First in New Family, Found Safe in Late-Stage Study
Bloomberg
Monday, November 8, 2010 - 9:31am
tags:
Pfizer, arthritis, tasocitinib
Depomed Posts Positive Earnings With Strong 2011 Outlook
Seeking Alpha
Monday, November 8, 2010 - 9:30am
tags:
earnings, Abbott Laboratories, Depomed
Teva sees $2.4b from respiratory operations by 2015
Globes, Israel
Sunday, November 7, 2010 - 11:54am
tags:
Teva Pharmaceuticals, Ventolin HFA, ProAir HFA, QNAZE, allergic rhinitis, Flonase, QVAR
Pharmasset Makes Remarkable Recovery on Hepatitis C Franchise
Seeking Alpha
Sunday, November 7, 2010 - 11:32am
tags:
Pharmasset, hepatitis C, nucleoside polymerase inhibitor, RG7128, Roche
Lilly Opens New Diabetes Research Center With Focus on China
Seeking Alpha
Sunday, November 7, 2010 - 11:30am
tags:
Eli Lilly, diabetes, China
A Small Step Back for MannKind?
Seeking Alpha
Sunday, November 7, 2010 - 11:29am
tags:
MannKind, inhaled insulin
Watson Pharmaceuticals: In-Depth Analysis for the September 2010 Quarter
Seeking Alpha
Sunday, November 7, 2010 - 11:28am
tags:
Watson Pharmaceuticals
Biotech Stocks Alert! (DNDN, MRX, JAZZ)
NewsWorthy Stocks
Sunday, November 7, 2010 - 11:27am
tags:
Jazz Pharmaceuticals, Dendreon, Medicis
Horizon Pharma Enters Into Exclusive Agreement With Mundipharma for Commercialization of LODOTRA
PR-Canada.net
Sunday, November 7, 2010 - 11:24am
tags:
Horizon Pharma, Mundipharma, Lodotra, arthritis, pain management, prednisone
Drugs linked to brain damage 30 years ago
Independent, UK
Sunday, November 7, 2010 - 11:20am
tags:
benzodiazepines, Roche, Wyeth, Class Action Lawsuit
Biotech Sector Weekly Rewind
The Street
Saturday, November 6, 2010 - 1:48pm
tags:
biotech
Data on Two Novel Investigational Bristol-Myers Squibb Compounds in Clinical Development for Patients with Rheumatoid Arthritis to Be Presented at the American College of Rheumatology Annual Scientific Meeting
istockanalyst
Saturday, November 6, 2010 - 1:42pm
tags:
Bristol-Myers Squibb, arthritis, BMS-945429, BMS-582949
Biotech firms squeezed by economy and hungry giants
Boston Globe, MA
Saturday, November 6, 2010 - 1:38pm
tags:
biotech
Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Bradenton Herald, FL
Saturday, November 6, 2010 - 1:25pm
tags:
Prolia, osteoporosis, Amgen
US Healthcare Market to Shine in Coming Years
SBWwire
Saturday, November 6, 2010 - 1:17pm
tags:
healthcare market
Biotech Initiatives in Biopharma Space: Would Darwin Approve?
Bioworld
Saturday, November 6, 2010 - 1:16pm
tags:
biotech
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Morningstar
Saturday, November 6, 2010 - 1:08pm
tags:
Lexicon Pharmaceuticals, LX2931, arthritis, LX1032, carcinoid syndrome, LX1031, irritable bowel syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.